$SYNA
SYNAPTICS Inc

2022 Q4 Form 10-Q Financial Statement

#000095017022021974 Filed on November 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $353.1M $448.1M $372.7M
YoY Change -16.03% 20.23% 13.49%
Cost Of Revenue $166.4M $192.4M $174.6M
YoY Change -14.84% 10.19% -9.95%
Gross Profit $186.7M $255.7M $198.1M
YoY Change -17.06% 29.08% 47.29%
Gross Profit Margin 52.87% 57.06% 53.15%
Selling, General & Admin $42.40M $44.70M $41.60M
YoY Change -4.29% 7.45% 17.85%
% of Gross Profit 22.71% 17.48% 21.0%
Research & Development $89.30M $89.50M $86.10M
YoY Change 0.45% 3.95% 6.43%
% of Gross Profit 47.83% 35.0% 43.46%
Depreciation & Amortization $41.00M $41.90M $30.40M
YoY Change 15.17% 37.83% 353.73%
% of Gross Profit 21.96% 16.39% 15.35%
Operating Expenses $140.6M $143.7M $137.5M
YoY Change -4.68% 4.51% 7.0%
Operating Profit $46.10M $112.0M $60.60M
YoY Change -40.59% 84.82% 910.0%
Interest Expense $7.700M $6.900M -$5.900M
YoY Change -235.09% -216.95% 22.92%
% of Operating Profit 16.7% 6.16% -9.74%
Other Income/Expense, Net -$6.700M -$8.300M -$5.900M
YoY Change 17.54% 40.68% 25.53%
Pretax Income $39.40M $103.7M $46.60M
YoY Change -45.2% 122.53% 3484.62%
Income Tax $17.40M $39.10M $5.900M
% Of Pretax Income 44.16% 37.7% 12.66%
Net Earnings $22.00M $64.60M $40.20M
YoY Change -68.35% 60.7% -1535.71%
Net Earnings / Revenue 6.23% 14.42% 10.79%
Basic Earnings Per Share $0.55 $1.62 $1.07
Diluted Earnings Per Share $0.55 $1.59 $0.99
COMMON SHARES
Basic Shares Outstanding 39.87M 39.63M 37.50M
Diluted Shares Outstanding 40.20 40.70 40.60M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $858.9M $911.8M $347.3M
YoY Change 49.66% 162.54% 42.39%
Cash & Equivalents $818.8M $867.8M $347.3M
Short-Term Investments $40.10M $44.00M
Other Short-Term Assets $32.60M $36.50M $43.70M
YoY Change -41.05% -16.48% 29.67%
Inventory $177.5M $179.4M $88.70M
Prepaid Expenses
Receivables $255.0M $284.1M $269.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.324B $1.412B $749.4M
YoY Change 23.2% 88.39% 20.87%
LONG-TERM ASSETS
Property, Plant & Equipment $65.90M $63.40M $92.10M
YoY Change 15.82% -31.16% -28.72%
Goodwill $816.4M $806.6M $570.0M
YoY Change -1.23% 41.51% -0.16%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $132.3M $128.0M $94.40M
YoY Change 19.4% 35.59% 37.61%
Total Long-Term Assets $1.401B $1.413B $1.033B
YoY Change -6.12% 36.81% -10.57%
TOTAL ASSETS
Total Short-Term Assets $1.324B $1.412B $749.4M
Total Long-Term Assets $1.401B $1.413B $1.033B
Total Assets $2.725B $2.825B $1.782B
YoY Change 6.15% 58.5% 0.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $82.70M $125.0M $109.7M
YoY Change -38.51% 13.95% 42.1%
Accrued Expenses $113.1M $128.2M $175.8M
YoY Change -45.34% -27.08% 7.79%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $6.000M $0.00
YoY Change
Total Short-Term Liabilities $299.3M $365.3M $303.5M
YoY Change -18.04% 20.36% 17.86%
LONG-TERM LIABILITIES
Long-Term Debt $973.9M $974.8M $394.5M
YoY Change -0.98% 147.1% 294.5%
Other Long-Term Liabilities $151.7M $159.6M $82.80M
YoY Change -2.0% 92.75% -5.15%
Total Long-Term Liabilities $1.126B $1.134B $477.3M
YoY Change -1.12% 137.67% 154.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $299.3M $365.3M $303.5M
Total Long-Term Liabilities $1.126B $1.134B $477.3M
Total Liabilities $1.425B $1.500B $780.8M
YoY Change -5.23% 92.07% -16.6%
SHAREHOLDERS EQUITY
Retained Earnings $1.125B $1.103B $821.2M
YoY Change 26.32% 34.33%
Common Stock $945.8M $931.8M $874.7M
YoY Change 8.99% 6.53%
Preferred Stock
YoY Change
Treasury Stock (at cost) $769.0M $707.9M $694.5M
YoY Change 10.73% 1.93%
Treasury Stock Shares
Shareholders Equity $1.300B $1.325B $1.001B
YoY Change
Total Liabilities & Shareholders Equity $2.725B $2.825B $1.782B
YoY Change 6.15% 58.5% 0.41%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $22.00M $64.60M $40.20M
YoY Change -68.35% 60.7% -1535.71%
Depreciation, Depletion And Amortization $41.00M $41.90M $30.40M
YoY Change 15.17% 37.83% 353.73%
Cash From Operating Activities $50.00M $78.50M $58.30M
YoY Change -59.15% 34.65% 796.92%
INVESTING ACTIVITIES
Capital Expenditures -$10.00M $6.200M $4.700M
YoY Change 17.65% 31.91% 20.51%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$11.10M $8.500M $0.00
YoY Change -97.83%
Cash From Investing Activities -$21.10M $2.300M -$4.700M
YoY Change -95.94% -148.94% -99.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -80.00M -35.00M -542.1M
YoY Change -114.45% -93.54% -11393.75%
NET CHANGE
Cash From Operating Activities 50.00M 78.50M 58.30M
Cash From Investing Activities -21.10M 2.300M -4.700M
Cash From Financing Activities -80.00M -35.00M -542.1M
Net Change In Cash -51.10M 43.80M -489.0M
YoY Change -132.74% -108.96% -16.15%
FREE CASH FLOW
Cash From Operating Activities $50.00M $78.50M $58.30M
Capital Expenditures -$10.00M $6.200M $4.700M
Free Cash Flow $60.00M $72.30M $53.60M
YoY Change -54.16% 34.89% 1961.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000817720
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q3 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2022Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2021Q3 syna Return Of Deposit Received From Vendor
ReturnOfDepositReceivedFromVendor
0
CY2022Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-25
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-24
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
000-49602
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
SYNAPTICS INCORPORATED
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0118518
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
1109 McKay Drive
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95131
CY2022Q3 dei City Area Code
CityAreaCode
408
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
904-1100
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $.001 per share
CY2022Q3 dei Trading Symbol
TradingSymbol
SYNA
CY2022Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
39870971
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
867800000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
824000000.0
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
44000000.0
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
52000000.0
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6200000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000000.0
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
284100000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
322100000
CY2022Q3 us-gaap Inventory Net
InventoryNet
179400000
CY2022Q2 us-gaap Inventory Net
InventoryNet
169700000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36500000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35600000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1411800000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
1403400000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
127700000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
122800000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63400000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
62900000
CY2022Q3 us-gaap Goodwill
Goodwill
806600000
CY2022Q2 us-gaap Goodwill
Goodwill
806600000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
357000000.0
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
390000000.0
CY2022Q3 syna Right Of Use Assets
RightOfUseAssets
58000000.0
CY2022Q2 syna Right Of Use Assets
RightOfUseAssets
61200000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
128000000.0
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
134000000.0
CY2022Q3 us-gaap Assets
Assets
2824800000
CY2022Q2 us-gaap Assets
Assets
2858100000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
125000000.0
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
141800000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
51900000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
90600000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
54200000
CY2022Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
79700000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
128200000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
145300000
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
6000000.0
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
6000000.0
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
365300000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
463400000
CY2022Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
974800000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
975700000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
159600000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
152600000
CY2022Q3 us-gaap Liabilities
Liabilities
1499700000
CY2022Q2 us-gaap Liabilities
Liabilities
1591700000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
68229513
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67745800
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39985261
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39621179
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
100000
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
100000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
931700000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
924100000
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28244252
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28124621
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
707900000
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
694500000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1900000
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1800000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1103100000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1038500000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1325100000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1266400000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2824800000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2858100000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
448100000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
372700000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
192400000
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
174600000
CY2022Q3 us-gaap Gross Profit
GrossProfit
255700000
CY2021Q3 us-gaap Gross Profit
GrossProfit
198100000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89500000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
86100000
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
44700000
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41600000
CY2022Q3 syna Amortization Of Intangible Assets Included In Operating Expense
AmortizationOfIntangibleAssetsIncludedInOperatingExpense
9500000
CY2021Q3 syna Amortization Of Intangible Assets Included In Operating Expense
AmortizationOfIntangibleAssetsIncludedInOperatingExpense
8400000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
1400000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
143700000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
137500000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
112000000.0
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
60600000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8300000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5900000
CY2022Q3 syna Loss On Redemption Of Convertible Notes
LossOnRedemptionOfConvertibleNotes
0
CY2021Q3 syna Loss On Redemption Of Convertible Notes
LossOnRedemptionOfConvertibleNotes
8100000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
103700000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46600000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39100000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5900000
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
500000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
64600000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
40200000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.59
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39.8
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37.5
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40.7
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40.6
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1266400000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
64600000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-100000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
64500000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8500000
CY2022Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
31400000
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13400000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
30500000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1325100000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
967200000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
40200000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
40200000
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7800000
CY2021Q3 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
27700000
CY2021Q3 syna Redemption Of Convertible Debt
RedemptionOfConvertibleDebt
-7300000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21200000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1001400000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
64600000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
40200000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
30500000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
21200000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6200000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
5200000
CY2022Q3 syna Acquired Intangibles Amortization
AcquiredIntangiblesAmortization
33000000.0
CY2021Q3 syna Acquired Intangibles Amortization
AcquiredIntangiblesAmortization
25200000
CY2022Q3 syna Loss On Redemption Of Convertible Notes
LossOnRedemptionOfConvertibleNotes
0
CY2021Q3 syna Loss On Redemption Of Convertible Notes
LossOnRedemptionOfConvertibleNotes
8100000
CY2022Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-5900000
CY2021Q3 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1400000
CY2022Q3 syna Change In Operating Lease Right Of Use Asset
ChangeInOperatingLeaseRightOfUseAsset
2700000
CY2021Q3 syna Change In Operating Lease Right Of Use Asset
ChangeInOperatingLeaseRightOfUseAsset
2400000
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
700000
CY2021Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1800000
CY2022Q3 syna Amortization Of Cost Of Development Services
AmortizationOfCostOfDevelopmentServices
2500000
CY2021Q3 syna Amortization Of Cost Of Development Services
AmortizationOfCostOfDevelopmentServices
2500000
CY2022Q3 syna Provision For Inventory Excess And Obsolescence
ProvisionForInventoryExcessAndObsolescence
0
CY2021Q3 syna Provision For Inventory Excess And Obsolescence
ProvisionForInventoryExcessAndObsolescence
-4500000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-500000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2022Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2021Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
500000
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1300000
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-37700000
CY2021Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
41400000
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9700000
CY2021Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2200000
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3200000
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5000000.0
CY2022Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3100000
CY2021Q3 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
9800000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-17600000
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
10700000
CY2022Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-38200000
CY2021Q3 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-12300000
CY2022Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-18900000
CY2022Q3 syna Account Receivable Bad Debt Charge
AccountReceivableBadDebtCharge
0
CY2021Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-6900000
CY2022Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-20000000.0
CY2021Q3 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
24000000.0
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
78500000
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
58300000
CY2022Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
7700000
CY2021Q3 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
CY2022Q3 syna Receipt Of Liquidation Payment On Equity Investment
ReceiptOfLiquidationPaymentOnEquityInvestment
800000
CY2021Q3 syna Receipt Of Liquidation Payment On Equity Investment
ReceiptOfLiquidationPaymentOnEquityInvestment
0
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6200000
CY2021Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4700000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2300000
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4700000
CY2022Q3 syna Payment For Redemption Of Convertible Notes
PaymentForRedemptionOfConvertibleNotes
0
CY2021Q3 syna Payment For Redemption Of Convertible Notes
PaymentForRedemptionOfConvertibleNotes
-505600000
CY2022Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8500000
CY2021Q3 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7800000
CY2022Q3 syna Payment For Payroll Taxes For Deferred Stock And Market Stock Units
PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits
31400000
CY2021Q3 syna Payment For Payroll Taxes For Deferred Stock And Market Stock Units
PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits
27700000
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13400000
CY2021Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2022Q3 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
-1500000
CY2021Q3 us-gaap Proceeds From Repayments Of Secured Debt
ProceedsFromRepaymentsOfSecuredDebt
0
CY2022Q3 syna Refundable Deposit Paid To Vendor
RefundableDepositPaidToVendor
0
CY2021Q3 syna Refundable Deposit Paid To Vendor
RefundableDepositPaidToVendor
-16600000
CY2022Q3 syna Return Of Deposit Received From Vendor
ReturnOfDepositReceivedFromVendor
2800000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-35000000.0
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-542100000
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2000000.0
CY2021Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-500000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
43800000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-489000000.0
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
824000000.0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
836300000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
867800000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
347300000
CY2022Q3 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
48800000
CY2021Q3 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
16700000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
6800000
CY2021Q3 us-gaap Interest Paid Net
InterestPaidNet
200000
CY2022Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4400000
CY2021Q3 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
3400000
CY2022Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1400000
CY2022Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1200000
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
29900000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
64600000
CY2022Q3 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
43100000
CY2022Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
27300000
CY2022Q2 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
61300000
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1800000
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2900000
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, including our expectations regarding the potential impacts on our business of the pandemic related to the novel coronavirus, or COVID-19, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span>
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
867800000
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
824000000.0
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1900000
CY2022 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
1800000
CY2022Q3 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Payments are generally due within three months of completion of the performance obligation and subsequent invoicing and therefore, do not include significant financing components.
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
40200000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39.8
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37.5
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0.9
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3100000
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40.7
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
40.6
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.62
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.59
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
94600000
CY2022Q2 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
92200000
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
84800000
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
77500000
CY2022Q3 us-gaap Inventory Net
InventoryNet
179400000
CY2022Q2 us-gaap Inventory Net
InventoryNet
169700000
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46100000
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
54000000.0
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
46100000
CY2022Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
44000000.0
CY2022Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
54000000.0
CY2022Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
52000000.0
CY2022Q3 syna Cash Held In Bank
CashHeldInBank
418800000
CY2022Q2 syna Cash Held In Bank
CashHeldInBank
811900000
CY2022Q3 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y10M24D
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
684400000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
327400000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
357000000.0
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
699700000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
309700000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
390000000.0
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33000000.0
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25200000
CY2022Q3 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The leases expire at various dates through fiscal year 2034, some of which include options to extend the lease for up to seven years.
CY2022Q3 syna Lease Expiration Year
LeaseExpirationYear
2034
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
3300000
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2800000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
58000000.0
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61200000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7400000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7600000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48700000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51500000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
56100000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
59100000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2700000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3000000.0
CY2022Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1400000
CY2021Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6600000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M24D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.044
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3900000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
10300000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9000000.0
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8800000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8100000
CY2022Q3 syna Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
28100000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
68200000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12100000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
56100000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
448100000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
372700000
CY2022Q3 syna Customer Obligation
CustomerObligation
73000000.0
CY2022Q2 syna Customer Obligation
CustomerObligation
88600000
CY2022Q3 syna Accrued Liabilities For Inventory Purchase
AccruedLiabilitiesForInventoryPurchase
12200000
CY2022Q2 syna Accrued Liabilities For Inventory Purchase
AccruedLiabilitiesForInventoryPurchase
14100000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7400000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7600000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35600000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
35000000.0
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
128200000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
145300000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
48700000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
51500000
CY2022Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
57600000
CY2022Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
52600000
CY2022Q3 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
34400000
CY2022Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
29100000
CY2022Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
18900000
CY2022Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
19400000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
159600000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
152600000
CY2022Q3 syna Redemptionofprincipalamountpercentage
Redemptionofprincipalamountpercentage
1
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5700000
CY2022Q3 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
4100000
CY2022Q3 syna Percentage Of Voting Capital Stock Of Certain Foreign Subsidiaries Collateralized
PercentageOfVotingCapitalStockOfCertainForeignSubsidiariesCollateralized
0.65
CY2022Q3 syna Percentageofnonvotingcapitalstock
Percentageofnonvotingcapitalstock
1
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
600000000.0
CY2028Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2028-12-02
CY2021Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0100
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
11200000
CY2022Q3 us-gaap Interest Expense
InterestExpense
6900000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32600000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35600000
CY2022Q3 syna Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense
-3800000
CY2021Q3 syna Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense
-5300000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
31185
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
61.50
CY2022Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3808
CY2022Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
88.53
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
27377
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
57.75
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1200000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39100000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5900000
CY2022Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
8400000
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
38200000
CY2022Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
2600000
CY2022Q3 syna Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued
IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued
100000
CY2022Q3 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q3 syna Number Of Product Categories
NumberOfProductCategories
3
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
448100000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
372700000
CY2022Q2 us-gaap Restructuring Reserve
RestructuringReserve
1400000
CY2021Q2 us-gaap Restructuring Reserve
RestructuringReserve
200000
CY2022Q3 us-gaap Restructuring Charges
RestructuringCharges
0
CY2021Q3 us-gaap Restructuring Charges
RestructuringCharges
1400000
CY2022Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
1200000
CY2021Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
400000
CY2022Q3 us-gaap Restructuring Reserve
RestructuringReserve
200000
CY2021Q3 us-gaap Restructuring Reserve
RestructuringReserve
1200000

Files In Submission

Name View Source Status
syna-20220924_cal.xml Edgar Link unprocessable
0000950170-22-021974-index-headers.html Edgar Link pending
0000950170-22-021974-index.html Edgar Link pending
0000950170-22-021974.txt Edgar Link pending
0000950170-22-021974-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
syna-20220924.htm Edgar Link pending
syna-20220924.xsd Edgar Link pending
syna-ex31_1.htm Edgar Link pending
syna-ex31_2.htm Edgar Link pending
syna-ex32_1.htm Edgar Link pending
syna-ex32_2.htm Edgar Link pending
syna-20220924_def.xml Edgar Link unprocessable
syna-20220924_lab.xml Edgar Link unprocessable
syna-20220924_pre.xml Edgar Link unprocessable
syna-20220924_htm.xml Edgar Link completed